Pathways of lymphatic spread in male urogenital pelvic malignancies

Radiographics

Volumn 31, Issue 1, 2011, Pages 135-160

  Paño, Blanca ^a   Sebastià, Carmen ^a   Buñesch, Laura ^a   Mestres, Judit ^a   Salvador, Rafael ^a   Macías, Napoleón G ^a   Nicolau, Carlos ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INGUINAL REGION; LYMPH NODE; LYMPH NODE METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PELVIS; RADIOGRAPHY; REVIEW; UROGENITAL TRACT TUMOR;

GROIN; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; PELVIS; TOMOGRAPHY, X-RAY COMPUTED; UROGENITAL NEOPLASMS;

EID: 79953802478     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.311105072     Document Type: Article

References (61)

1. Park JM, Charnsangavej C, Yoshimitsu K, Herron DH, Robinson TJ, Wallace S. Pathways of nodal metastasis from pelvic tumors: CT demonstration. RadioGraphics 1994;14(6):1309-1321.
2. Husband JE, McVicar D. Testicular germ tumor. In: Husband JE, Reznek RH, eds. Imaging in oncology. Oxford, England: Isis Medical Media, 1998; 259-276.
3. Koh DM, Hughes M, Husband JE. Cross-sectional imaging of nodal metastases in the abdomen and pelvis. Abdom Imaging 2006;31(6):632-643.
4. Koh DM, Husband JE. Patterns of recurrence of bladder carcinoma following radical cystectomy. Cancer Imaging 2003;3(2):96-100.
5. Spencer JA, Golding SJ. Patterns of lymphatic metastases at recurrence of prostate cancer: CT findings. Clin Radiol 1994;49(6):404-407.
6. Grubnic S, Vinnicombe SJ, Norman AR, Husband JE. MR evaluation of normal retroperitoneal and pelvic lymph nodes. Clin Radiol 2002;57(3):193-200; discussion 201-204.
7. Vinnicombe SJ, Norman AR, Nicolson V, Husband JE. Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology 1995; 194(2):349-355.
8. Dorfman RE, Alpern MB, Gross BH, Sandler MA. Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 1991;180(2): 319-322.
9. Oyen RH, Van Poppel HP, Ameye FE, Van de Voorde WA, Baert AL, Baert LV. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994;190(2):315-322.
10. Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ. Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a threedimensional T1-weighted magnetization-prepared rapid gradient-echo sequence. AJR Am J Roentgenol 1996;167(6):1503-1507.
11. Roy C, Le Bras Y, Mangold L, et al. Small pelvic lymph node metastases: evaluation with MR imaging. Clin Radiol 1997;52(6):437-440.
12. Hilton S, Herr HW, Teitcher JB, Begg CB, Castéllino RA. CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR Am J Roentgenol 1997;169(2):521-525.
13. Lien HH, Stenwig AE, Ous S, Fosså SD. Influence of different criteria for abnormal lymph node size on reliability of computed tomography in patients with non-seminomatous testicular tumor. Acta Radiol Diagn (Stockh) 1986;27(2):199-203.
14. Stomper PC, Fung CY, Socinski MA, Jochelson MS, Garnick MB, Richie JP. Detection of retroperitoneal metastases in early-stage nonseminomatous testicular cancer: analysis of different CT criteria. AJR Am J Roentgenol 1987;149(6):1187-1190.
15. Leibovitch L, Foster RS, Kopecky KK, Donohue JP. Improved accuracy of computerized tomography based clinical staging in low stage nonseminomatous germ cell cancer using size criteria of retroperitoneal lymph nodes. J Urol 1995;154(5):1759-1763.
16. Bellin MF, Lebleu L, Meric JB. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 2003;28(2):155-163.
17. Hulnick DH, Megibow AJ, Naidich DP, Hilton S, Cho KC, Balthazar EJ. Abdominal tuberculosis: CT evaluation. Radiology 1985;157(1):199-204.
18. Huppert BJ, Farrell MA. Case 60: Cavitating mesenteric lymph node syndrome. Radiology 2003;228 (1):180-184.
19. Krishnam MS, Suh RD, Tomasian A, et al. Postoperative complications of lung transplantation: radiologic findings along a time continuum. RadioGraphics 2007;27(4):957-974.
20. Husband JE. CT/MRI of nodal metastases in pelvic cancer. Cancer Imaging 2002;2(2):123-129.
21. Noworolski SM, Fischbein NJ, Kaplan MJ, et al. Challenges in dynamic contrast-enhanced MRI imaging of cervical lymph nodes to detect metastatic disease. J Magn Reson Imaging 2003;17(4): 455-462.
22. Pizzocaro G, Piva L, Nicolai N. Improved management of nodal metastases of squamous carcinoma of the penis [abstr]. J Urol 1995;153(suppl):246.
23. Singh I, Khaitan A. Current trends in the management of carcinoma penis: a review. Int Urol Nephrol 2003;35(2):215-225.
24. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58(6):843-848.
25. Saokar A, Braschi M, Harisinghani M. Lymphotrophic nanoparticle enhanced MR imaging (LNMRI) for lymph node imaging. Abdom Imaging 2006;31 (6):660-667.
26. Heesakkers RA, Hövels AM, Jager GJ, et al. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 2008;9(9):850-856.
27. Harisinghani MG, Saksena M, Ross RW, et al. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology 2005;66(5): 1066-1071.
28. Deserno WM, Harisinghani MG, Taupitz M, et al. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. Radiology 2004;233(2):449-456.
29. Wu L, Cao Y, Liau C. Diagnostic performance of USPIO MRI for lymph node metastases in different body regions: a meta-analysis. Eur J Radiol (in press).
30. Mouli SK, Zhao LC, Omary RA, Thaxton CS. Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors. Nat Rev Urol 2010;7(2):84-93.
31. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008;18(9):1937-1952.
32. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188(6):1622-1635.
33. Thoeny HC, Triantafyllou M, Birkhaeuser FD, et al. Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients. Eur Urol 2009;55(4): 761-769.
34. Judenhofer MS, Wehrl HF, Newport DF, et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 2008; 14(4):459-465.
35. Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 2009;36(suppl 1): S113-S120.
36. Ratib O, Becker M, Vallée JP, et al. Whole body PET-MRI scanner: first experience in oncology [abstr]. J Nucl Med 2010;51(suppl 2):165.
37. Bouchelouche K, Oehr P. Recent developments in urologic oncology: positron emission tomography molecular imaging. Curr Opin Oncol 2008;20(3): 321-326.
38. Oyama N, Akino H, Kanamaru H, et al. 11C-acetate PET imaging of prostate cancer. J Nucl Med 2002;43(2):181-186.
39. Scattoni V, Picchio M, Suardi N, et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol 2007;52(2):423-429.
40. Schiavina R, Scattoni V, Castellucci P, et al. 11Ccholine positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol 2008;54(2):392-401.
41. Picchio M, Treiber U, Beer AJ, et al. Value of 11Ccholine PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings. J Nucl Med 2006;47(6):938-944.
42. Albers P, Bender H, Yilmaz H, Schoeneich G, Biersack HJ, Mueller SC. Positron emission tomography in the clinical staging of patients with stage I and II testicular germ cell tumors. Urology 1999;53(4): 808-811.
43. Hain SF, O'Doherty MJ, Timothy AR, Leslie MD, Partridge SE, Huddart RA. Fluorodeoxyglucose PET in the initial staging of germ cell tumours. Eur J Nucl Med 2000 May;27(5):590-594.
44. Morisawa N, Koyama T, Togashi K. Metastatic lymph nodes in urogenital cancers: contribution of imaging findings. Abdom Imaging 2006;31(5): 620-629.
45. Weckermann D, Holl G, Dorn R, Wagner T, Harzmann R. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int 2007;99(5): 1036-1040.
46. American Joint Committee on Cancer. Cancer staging atlas. Chicago, Ill: Springer, 2007.
47. Singh AK, Saokar A, Hahn PF, Harisinghani MG. Imaging of penile neoplasms. RadioGraphics 2005; 25(6):1629-1638.
48. Misra S, Chaturvedi A, Misra NC. Penile carcinoma: a challenge for the developing world. Lancet Oncol 2004;5(4):240-247.
49. Solsona E, Algaba F, Horenblas S, Pizzocaro G, Windahl T; European Association of Urology. EAU guidelines on penile cancer. Eur Urol 2004;46(1): 1-8.
50. Pandey D, Mahajan V, Kannan RR. Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol 2006;93(2):133-138.
51. Slaton JW, Morgenstern N, Levy DA, et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J Urol 2001;165(4):1138-1142.
52. Villavicencio H, Rubio-Briones J, Regalado R, Chéchile G, Algaba F, Palou J. Grade, local stage and growth pattern as prognostic factors in carcinoma of the penis. Eur Urol 1997;32(4):442-447.
53. Solsona E, Iborra I, Rubio J, Casanova JL, Ricós JV, Calabuig C. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. J Urol 2001;165(5):1506-1509.
54. Ravizzini GC, Wagner M, Borges-Neto S. Positron emission tomography detection of metastatic penile squamous cell carcinoma. J Urol 2001;165(5): 1633-1634.
55. Lont AP, Horenblas S, Tanis PJ, Gallee MP, van Tinteren H, Nieweg OE. Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy. J Urol 2003;170(3):783-786.
56. Woodward PJ, Sohaey R, O'Donoghue MJ, Green DE. Tumors and tumorlike lesions of the testis: radiologic-pathologic correlation. RadioGraphics 2002;22(1):189-216.
57. Ray B, Hajdu SI, Whitmore WF Jr. Proceedings: distribution of retroperitoneal lymph node metastases in testicular germinal tumors. Cancer 1974;33 (2):340-348.
58. Cremerius U, Effert PJ, Adam G, et al. FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med 1998;39(5):815-822.
59. Simms MS, Mann G, Kockelbergh RC, Mellon JK. The management of lymph node metastasis from bladder cancer. Eur J Surg Oncol 2005;31(4): 348-356.
60. Abol-Enein H, El-Baz M, Abd El-Hameed MA, Abdel-Latif M, Ghoneim MA. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study-a single center experience. J Urol 2004;172(5 pt 1): 1818-1821.
61. Barentsz JO, Jager GJ, van Vierzen PB, et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 1996;201(1):185-193.